Treatment of screen detected ductal carcinoma in situ: a silver lining within a grey cloud?
Open Access
- 1 June 1990
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 61 (6) , 795-796
- https://doi.org/10.1038/bjc.1990.179
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- IN-SITU BREAST CANCER: THE EORTC CONSENSUS MEETINGThe Lancet, 1989
- Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrenceCancer, 1989
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- TAMOXIFEN AND BENIGN BREAST PROBLEMSThe Lancet, 1987
- OVERVIEW OF RANDOMIZED TRIALS OF POSTOPERATIVE ADJUVANT RADIOTHERAPY IN BREAST-CANCER1987
- TAMOXIFEN AND CONTRALATERAL BREAST CANCERThe Lancet, 1985
- REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHYThe Lancet, 1985
- Ten- to Fourteen-Year Effect of Screening on Breast Cancer Mortality2JNCI Journal of the National Cancer Institute, 1982